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Aging is associated with reduced function, degenerative changes, and increased neuroinﬂammation of
the central nervous system (CNS). Increasing evidence suggests that changes in microglia cells contribute
to the age-related deterioration of the CNS. The most prominent age-related change of microglia is
enhanced sensitivity to inﬂammatory stimuli, referred to as priming. It is unclear if priming is due to
intrinsic microglia ageing or induced by the ageing neural environment. We have studied this in Ercc1
mutant mice, a DNA repair-deﬁcient mouse model that displays features of accelerated aging in multiple
tissues including the CNS. In Ercc1 mutant mice, microglia showed hallmark features of priming such as
an exaggerated response to peripheral lipopolysaccharide exposure in terms of cytokine expression and
phagocytosis. Speciﬁc targeting of the Ercc1 deletion to forebrain neurons resulted in a progressive
priming response in microglia exempliﬁed by phenotypic alterations. Summarizing, these data show that
neuronal genotoxic stress is sufﬁcient to switch microglia from a resting to a primed state.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Microglia, the resident central nervous system (CNS) myeloid
cell population, are the most prominent immune cells in the brain.
It is well known that microglia in the aged brain show speciﬁc
changes like enhanced sensitivity to proinﬂammatory stimuli
(Henry et al., 2009; Norden and Godbout, 2013; Sierra et al., 2007).
Such a hyper-responsive state is called priming and is viewed as a
phenotypewith a lower threshold to “switch” to a proinﬂammatoryience, Section Medical Physi-
Center Groningen, Antonius
el.: þ31 (0)50 363 2701.
.M. Boddeke).
ll rights reserved.state (Lull and Block, 2010). Priming of microglia in the aged brain
may result from chronic proinﬂammatory cues of the aging envi-
ronment and is suggested to impair neuronal function and may
underlie or promote neurodegeneration (Lull and Block, 2010;
Norden and Godbout, 2013; Ransohoff and Perry, 2009).
Accumulation of nuclear DNA damage has been proposed as a
critical factor for aging (Hoeijmakers, 2009). Genotoxic stress
resulting from DNA damage accumulation evokes cell cycle check-
point responses (Jackson and Bartek, 2009; Zhou et al., 2001)
leading to cell cycle arrest and senescence (Matheu et al., 2007).
DNA damage induces the expression of immune-stimulatory sur-
face ligands and increased secretion of proinﬂammatory cytokines
(Rodier et al., 2009) by senescent cells. This process most likely
activates inﬂammatory pathways and immune responses that
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Campisi, 2011). In mice, DNA damage has been suggested to
induce a phenotype in postmitotic neurons resembling cellular
senescence and the number of senescent-like neurons increased
with age (Jurk et al., 2012). Also, DNA damage has been shown to
occur as part of normal brain activity (Suberbielle et al., 2013) and
during brain aging (Dorszewska and Adamczewska-Goncerzewicz,
2004; Hamilton et al., 2001).
A causal relationship between accumulating DNA damage and
age-related neurodegeneration has recently been suggested in
Ercc1 mutant mice (Ercc1D/) that are deﬁcient in DNA repair. In
Ercc1D/ mice, a decrease in neuronal synaptic plasticity, deﬁcits
in learning behavior, and deterioration of neurons has been
reported in addition to considerable glial activation, ﬁndings anal-
ogous to physiological aging (Borgesius et al., 2011). Ercc1, together
with XPF, forms an endonuclease essential for nucleotide excision
repair (NER) (Houtsmuller et al., 1999). In addition, Ercc1 is also
involved in double-strand break repair (Ahmad et al., 2008) and
interstrand cross-link repair (Bergstralh and Sekelsky, 2008). In
addition to DNA damage accumulation, the defects seen in Ercc1D/
mice might also be the consequence of perturbed RNA polymerase
II transcription initiation as it has been shown that Ercc1 is involved
in RNA polymerase II assembly on promoters (Kamileri et al., 2012).
We have used the Ercc1D/ mouse model to determine if genotoxic
stress and transcriptional blockage in neurons leads to microglial
priming and if so, is microglia “switching” to a primed state the
result of intrinsic damage or the consequence of perturbed
neuroneglia interaction. Here we report that the Ercc1D/mutation
resulted in pronounced microglia priming, reﬂected by enhanced
endotoxin sensitivity. Furthermore, selective targeting of the Ercc1-
deﬁciency to forebrain neurons was sufﬁcient to “switch” microglia
to a primed state; strongly suggesting that neuronal dysfunction as
a result of genotoxic stress is sufﬁcient to prime microglia.
2. Methods
2.1. Generation and breeding of mutant mice
All experiments were approved by the Institutional Animal Care
and Use Committee of the University of Groningen and the Erasmus
University Medical Center Rotterdam, in accordance to the Dutch
animal care and use laws. The generation and characterization of
nucleotide excision repair-deﬁcient Ercc1D/þ and Ercc1/þ mice has
been previously described (Weeda et al., 1997). Ercc1D/ mice were
obtained by crossing Ercc1/þ with Ercc1D/þ mice of C57Bl6J and
FVB backgrounds to yield Ercc1D/ mutants in a C57Bl6J/FVB F1
hybrid background.Wild-type (WT) littermates of the same genetic
background, age, and sex were used as controls. The C57BL6J/FVB
hybrid background prevents characteristics like blindness on an
FVB background or deafness on a C57BL6J background. Unless
speciﬁed, we used Ercc1D/ mice aged 16 weeks and of both sexes
for the experiments with age/sex matched genetic controls. For
conditional mutant studies, an Ercc1 allele ﬂanked by loxP sites was
used (ﬂoxed Ercc1, Ercc1f/f; Doig et al., 2000). The aCamk2 promoter
was used as a Cre driver (Tsien et al., 1996a, 1996b) and expression
of this promoter is speciﬁc for postmitotic excitatory neurons
(Madisen et al., 2010). Camk2-Cre/Ercc1f/ mice were obtained by
crossing Ercc1f/f (FVB) with Camk2-Cre/Ercc1þ/ mice (C57BL6J). As
controls, Camk2-Cre/Ercc1f/þ littermates were used. hGFAP-Cremice
were used for Ercc1 deletion in astrocytes (Zhuo et al., 2001). Mice
were housed in individually ventilated cages with ad libitum
access to water and standard mouse food (CRM pellets, SDS BP
Nutrition Ltd; gross energy content 18.36 kJ/g dry mass, digestible
energy 13.4 kJ/g) and received liqueﬁed food in case of motor
disabilities.2.2. Histologic staining and morphometric analysis
Animals were transcardially perfused under pentobarbital
anesthesia with saline followed by 4% paraformaldehyde. Brains
were post ﬁxed for 24 hours, equilibrated in 25% sucrose solution,
and cryosectioned at 40 mm for regular immunohistochemistry or
80 mm formorphometric analysis. For blocking and incubation steps
involving antibodies, 0.3% Triton X-100 (Merck, Darmstadt, Ger-
many) in PBSwasused.Antigen retrieval (for Iba1-Mac2 co-staining)
was done in 0.01 M citrate buffer (pH 6.0), followed by heating in a
household microwave device at 800 W for 18 minutes. For CD68
staining, the sections were preincubated in 25mM citrate buffer, pH
8.6, at 80 C, for 1 hour. Following the blocking step sections were
incubated in primary antibody overnight. The primary antibodies
used are Iba1 (Wako, Japan), Mac2 (Cedarlane, Canada), Ki67 (Dako
Cytomation, Eindhoven, the Netherlands), and CD68 (Dako Cyto-
mation, Eindhoven, the Netherlands). As secondary antibodies,
Alexaﬂuor 488 (Molecular probes, Oregon, USA) and Cy3 (Jackson
Immuno Research, Palo alto, USA) conjugated antibodies were used.
The sections were mounted on gelatin (Merck)-poly-L-lysine
(Sigma, Zwijndrecht, the Netherlands) coated glass slides and
embedded in Mowiol (Calbiochem, Zwijndrecht, the Netherlands).
For morphometric analysis, confocal images of microglia were
made with a 63 objective on a Leica SP2 confocal laser-scanning
microscope at 1-mm intervals along the z-axis. Confocal images
were then deconvoluted using Huygens professional imaging
software (SVI). Topology of the branching cell was reconstructed in
3 dimensions andmeasurements quantiﬁed after retracing with the
help of the Filament Tracer function of the Imaris 7.0 software
(Bitplane). Care was taken that the analyzed cell within the frame
was cropped (75e200 mm range) according to the extent of
branches that were clearly connected to the cell body of interest
and fully separable from crossing branches of other cells. Statistical
analysis of the quantiﬁed measures was performed using multi-
variate analysis of covariance (MANCOVA) as the cellular parame-
ters studied can inﬂuence each other. For Ki67 staining, 3 sections
were counted per mouse (n ¼ 3), after which the counted values
were divided for the area analyzed (3e6 mm2) to obtain cells/
square mm. Asterisks indicate p-value < 0.05 with 1-tailed un-
paired t-tests.
2.3. Acute isolation of microglia from adult mouse brain
Animals were sacriﬁced by means of transcardial saline perfu-
sion under inhalation anesthesia with isoﬂurane and/or oxygen.
The brains were isolated and kept in ice-cold medium A (HBSS
containing 0.6 % glucose and 15 mM HEPES buffer). From the
collected tissue microglia were isolated at high purity (>98%) using
a discontinuous Percoll gradient as described previously (De Haas
et al., 2007) at 4 C. Brieﬂy, the tissue was mechanically dissoci-
ated to form a single cell suspension (Glass potter, Braun Melsun-
gen, Germany). After centrifugation (10 minutes, 220g), the cell
pellet was subjected to density gradient separation using Percoll
solutions with different densities. Isotonic Percoll solution (100%,
density 1123 g/mL), 9 volume parts of Percoll (density 1.13 g/mL, GE
Healthcare, Uppsala, Sweden, 17e0891) were mixed with one vol-
ume part of 10 HBSS. Percoll solutions with various percentages
were prepared via dilution of 100% Percoll with 1 PBS. The cell
pellet was resuspended in 75% Percoll, overlaid with 25% Percoll,
and ﬁnally with PBS and centrifuged at a force of 800g for
25 minutes. After centrifugation, microglia were collected from the
75%e25% Percoll interface, washed with PBS, and pelleted by
centrifugation. The cell pellet was resuspended in culture medium
(DMEM containing 5% FCS, 1% penicillin and/or streptomycin, and
1% sodium pyruvate) for functional assays. For RNA isolation, the
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density of 1.03 g/mL (40 mL myelin gradient buffer, 11.7 mL Percoll,
and 1.3 mL 1.5 M NaCl). A gradient was prepared by overlaying with
PBS and centrifuged at 950g for 20 minutes. The resulting cell pellet
was separated from myelin and cell debris and stained for ﬂow
cytometry with antibodies against CD11b and CD45 (see Section 2.4
for details).
2.4. Flow cytometry
Cells from either the 75/25 interface or the myelin gradient
buffer pellet were resuspended in medium A (without phenol red)
and Fc blocked with 1% anti-CD16/32 (eBiosciences, the
Netherlands) for 15 minutes, stained for different surface markers
for 20 minutes and washed with PBS for subsequent ﬂow cyto-
metric analysis. The surface expression of markers was measured
with a FACSCalibur ﬂow cytometer (Becton Dickinson) and
analyzed using FloJo software. To determine the purity of the
microglia preparation a small sample of the attained cell suspen-
sion was stained for CD11b and CD45 together with a live cell
marker DRAQ5 (Biostatus Ltd, UK) for CD11bhigh/CD45low/DRAQ5þ
cells (live microglia). For immunophenotyping of mouse microglia
cells the following antibodies were used: phycoerythrin (PE)
coupled rat anti-mouse CD11b (Clone M1/70, eBiosciences), ﬂuo-
rescein isothiocyanate coupled rat anti-mouse CD45 (Clone 30-F11,
eBiosciences), PE coupled rat anti-mouse TREM2b (Clone 237920,
R&Dsystems), ﬂuorescein isothiocyanate coupled rat anti-mouse
CD14 (Clone Sa2-8, eBiosciences) and PE coupled rat anti-mouse
CD36 (Clone 72-1, eBiosciences).
2.5. Lipopolysaccharide injections
Animals were intraperitoneally injected with 1 mg/kg lipo-
polysaccharide (LPS) (Escherichia coli 0111:B4; Sigma-Aldrich, St
Louis, MO, USA; L4391) or saline. Three (for RNA isolation) or 18 (for
immunohistochemistry) hours after injection, the animals were
sacriﬁced and the brains were dissected and processed as described
previously. Subsequently, CD11bhigh/CD45low cells were sorted in
RNA lysis buffer (Qiagen, Germany) for real time PCR analysis.
2.6. Analysis of microglia priming by quantitative real time PCR
RNA was extracted using the RNeasy Micro kit and concentra-
tions were determined with a NanoDrop (ND1000). Complemen-
tary DNA was synthesized using RevertAid M-MuLV Reverse
Transcriptase, Ribolock RNase Inhibitor, and M-MLV buffer (all
Fermentas GmbH, Germany). The PCR reaction contained iQ SYBR
Green Supermix (Bio-Rad) and was performed on an ABI 7900HT
machine (Applied Biosystems). The primers were designed with
NCBI Primer Blast software and ordered from Biolegio, the
Netherlands. Supplementary Table 1 contains the list of primers
used in the study.
2.7. Phagocytosis assay
After isolation, cells were resuspended in culture medium,
seeded in 8 well Lab-Tek II Chambered Coverglass (Nunc) at a
density of 5000 cells per well and allowed to attach for 20 mi-
nutes. Two hours after seeding, the medium was replaced with
culture medium containing 25 mg/mL of pHrodo E. coli Bio-
Particles conjugate (Life technologies, Molecular probes, USA).
The cells were subsequently imaged for 18 hours with a Solamere
Nipkow spinning disc confocal laser scanning microscope
mounted on a Leica DM IRE2 inverted microscope equipped with
a Stanford Photonics XR/Mega-10I (intensiﬁed) CCD camera andan ASI MS2000 Piezo motorized stage, (37 C and 5% CO2). To
excite pHrodo, the 568 nm laser line of a dynamic Krypton laser
was used. During image acquisition, an HC PL APO CS 10 dry
objective was used. A bright ﬁeld and a red channel image
(pHrodo emission) were acquired every 5 minutes at each con-
dition. Multiple cells were selected as regions of interest based on
the bright ﬁeld images. At the end of the imaging session, cells
were stained with Syto13 (Life Technologies), an indicator for cell
viability. Syto13-positive cells were selected for quantiﬁcation.
The intensity of the regions of interest in the red channel images
was measured in each frame of the entire image stack with the
help of an ImageJ plug in (written by K. Sjollema; Microscopy
Center, University Medical Center Groningen, University of Gro-
ningen). The data were plotted as a time versus intensity, and the
time needed to reach half maximum response for each cell was
determined.
2.8. Determination of reactive oxygen species production
Production of reactive oxygen species by acutely isolated
microglia was determined by detecting the conversion of non-
ﬂuorescent H2DCFDA (20,70-dichlorodihydroﬂuorescein diacetate;
Life Technologies) into ﬂuorescent DCF (20,70-dichloroﬂuorescein)
with ﬂow cytometry. Cell suspension (100 mL) containing 2 
104 cells was incubated, with or without H2DCFDA for 20 minutes
at 37 C in polystyrene FACS tubes, after which ﬂuorescence was
determined using ﬂow cytometry. Since the reagent is prone to
oxidation, precautions were taken to prepare suspensions just
before the experiment and no wash steps were used. Cells treated
with vehicle (DMSO) or 40 nM adenosine triphosphate were used
as negative and positive controls, respectively. The mean ﬂuo-
rescence intensity of DCF after subtraction of the background
ﬂuorescent values from negative controls was plotted for the
indicated conditions.
2.9. Transcriptional proﬁling and network analysis
Microglia were sorted (see Section 2.4 for details) from 16
Ercc1D/ and control mice aged 4-month-old and RNA was isolated
with the Qiagen RNeasy Kit. RNA quality and concentration was
assessed with a BioRad Bioanalyzer. After ampliﬁcation (Nugen
Ovation RNA ampliﬁcation kit), RNA was labeled and hybridized to
Illumina mouse-ref8 V2.0 expression beadchip microarrays.
Genomestudio (version 1.9.0) was used to generate raw expression
values, whichwere preprocessed and analyzed by project R (version
2.15.1) and BioConductor package Limma (version 1.8.18).
Transcriptional proﬁling was followed by Weighted Gene
Co-expression Network Analysis (WCGNA) (Langfelder and
Horvath, 2008). WCGNA deﬁnes co-expression relationships
between all pairs of genes in the transcriptional data set resulting
in a network of interconnected genes. Groups of genes that
exhibit similar behavior across the data set can be identiﬁed as
modules. WGCNA was performed using a soft-power (b) value of
4, based on scale free criteria. Genes with low topological overlap
were ﬁltered from the analysis resulting in a network of the 2.904
most connected genes. Only modules that signiﬁcantly associated
to the genotype were used for further analysis. Genes were or-
dered according to their module membership to generate gene
lists (kME; Korrelation Module EigenGene-table) ranking genes
by intramodular connectivity (Zhang and Horvath, 2005). Genes
in modules often share common regulatory mechanisms or are
involved in related cellular functions (Dewey et al., 2011;
Langfelder et al., 2013; Mason et al., 2009; Winden et al.,
2009). The Benjamini Hochberg multiple testing corrected
p-value was generated by the p.adjust function of R-package
Fig. 1. Quantitativemorphology analysis of Ercc1D/microglia. (A) Microgliamorphology in cortex andmedulla ofWTand Ercc1D/ brain. Morphology in 4- and 16-week-oldWT brain
is similar, only 16-week-old brains are depicted. (B) Confocal reconstruction of WT and Ercc1D/ microglia (16 weeks) from cortex and medulla (scale bar ¼ 20 mm). Analyses of
morphologic parameters fromWTand Ercc1D/microglia (16weeks; black¼WT, gray¼ Ercc1D/) in cortex, dentate gyrus (DG), thalamus, andmedulla of (C) total cell somavolume (D)
total length of processes, and (E) diameter of primary processes in individual microglia, revealed that Ercc1D/ microglia have larger cell body size, process length, and thickened
primary processes compared with WT microglia (n ¼ 30) reconstructed cells from each region from 3 WT and Ercc1D/ mice. Statistical analysis was performed with an MANCOVA
analysis, * p < 0.05; ** p < 0.01; *** p < 0.005 and ns is not signiﬁcant. Abbreviations: Ercc1D/, Ercc1 mutant mice; MANCOVA, multivariate analysis of covariance; WT, wild type.
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adjusted p value below 0.01 were used as input for ingenuity
pathway analysis (IPA). Heatmaps were generated using heat-
map.2 function of Bioconductor Package gplots 3.86 software (Hu
et al., 2008).
2.10. Statistical analyses
MANCOVA is a statistical method to cover cases where there is
more than one dependent variable and where the control of cova-
riates is required. A covariate represents a source of variation that
has not been controlled in the experiment and is believed to affectthe dependent variable. For instance, in analysis of cellular
morphology, thickening of processes might alter process length.
MANCOVA statistical design can “factor out” the error introduced
by such covariants thereby showing if individual parameters are
altered. We therefore used this statistic method for quantitative
morphometric analysis. Ki67 proliferation datawere analyzed using
1-tailed unpaired t-tests. All other experiments used 1-way or
multiple-way analysis of variance, followed by post hoc analysis
with Bonferroni test (GraphPad Prism 5). In the ﬁgures, the p-value
of the analysis of variance, and the post hoc tests are indicated.
Graphs show both the distribution of the individual values, the
resulting mean, and the standard error of the mean (SEM).
Fig. 2. Increase in microglia number in Ercc1D/ mice. Staining of Ki67 positive cells in (A) 16-week-old WT and (B) Ercc1D/ brains showed a higher number of proliferating cells in
Ercc1D/ with a uniform distribution throughout the brain. In WT brain, proliferating cells are predominantly located in the subventricular zone (SVZ). Proliferating cells in WT (C)
and Ercc1D/ (D) mice were microglia based on Ki67 (red) and Iba1 (green) co-expression; nuclei were counterstained with DAPI (blue). Quantitatively, Ki67 positive cells were
increased in Ercc1D/ brains. Scale bars are 50 mm. (E) Ki67-positive microglia per surface area, or as a percentage of total proliferating cells, were increased in Ercc1D/ brain. In the
brain stem of Ercc1D/ mice, most Ki67-positive cells were Iba1-positive microglia (F; indicated by white arrows). Scale bar is 10 mm. * p < 0.05; ** p < 0.01. Abbreviations: ac,
anterior commissure; CA1/CA3, corn ammonis 1/3; cc, corpus callosum; cp, cerebral crus; DG, dentate gyrus; Ercc1D/, Ercc1mutant mice; LS, lateral septal nucleus; NCx, neocortex;
Pir, piriform cortex; Str, striatum; Th, thalamus; WT, wild type. (Please refer to Neurobiology of Aging online for color reproduction.)
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3.1. Age-dependent changes in microglia morphology in Ercc1D/
mice
Neuropathological visualization of local microglial morphology
has been used to infer central nervous system distress (Streit et al.,
1999, 2000). To investigate the effect of DNA repair deﬁciency-
associated aging on microglia morphology, sections from Ercc1D/
mice and WT littermates were stained for the microglia marker
Iba1 at the age of 4 and 16 weeks. At 4 weeks, minor alterations in
microglia morphology in the cortex were observed, whereas in the
medulla, changes in microglia morphology were more pronounced
(Fig. 1A). Differences in microglial morphology between WT and
Ercc1D/mice were apparent at the age of 16 weeks throughout the
brain including the cortex and medulla. Using confocal microscopy,
followed by 3D reconstruction, microglia morphologies in WT and
Ercc1D/ mice were compared. In WT brain, microglia extended
thin ramiﬁed processes, whereas in Ercc1D/ mice microglia
possessed hypertrophic, thickened processes, and enlarged cell
bodies (Fig. 1B).
Morphometric quantiﬁcation revealed that Ercc1D/ microglia
had a signiﬁcantly increased cell soma volume in all brain regions
analyzed (frontal cortex, dentate gyrus, thalamus, and medulla;Fig. 1C). The total process length of Ercc1D/ microglia was longer
than WT in the cortex and dentate gyrus but not in the thalamus
and medulla (Fig. 1D). The primary processes in Ercc1D/ microglia
were signiﬁcantly thickened in all brain areas tested (Fig. 1E). The
degree of ramiﬁcation, quantiﬁed by pseudo-coloring different
levels of branching and counting of the number of segments at each
level, was not signiﬁcantly different between Ercc1D/ andWTmice
(Supplementary Fig. 1). The observed morphologic changes
resemble previously reported microglia phenotypes referred to as
“hypertrophic” (Ayoub and Salm, 2003; Streit, 2000), “reactive”
(Gomide et al., 2005), or “intermediate” (Karperien et al., 2013).
3.2. Increased microglia proliferation in Ercc1D/ mice
In Ercc1D/ mice a pronounced increase in microglia was
observed. To conﬁrm that the observed increased number of
microglia was because of increased proliferation, the number of
proliferating cells was determined using Ki67 staining. In WT brain,
most proliferating cells were localized to the neurogenic niches;
note the high density of Ki67þ cells in the sub-ventricular zone
(Fig. 2A), where the Ercc1D/ brain containedmuchmore Ki67þ cells
with no apparent regional distribution (Fig. 2B) although occasional
hotspots with a high density of Ki67þ cells were noticed frequently
in the brain stem (Fig. 2F). The number of Ki67þ cells/mm2 was
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Most Ki67þ cells in these regions were microglia, indicated by co-
staining with Iba1 (Fig. 2F). Quantitative analysis indicated a 10-
fold increase in the number of Ki67-Iba1 positive cells in the
neocortex (Fig. 2CeE). When represented as percentage of the total
number of proliferating cells, microglia constituted two-thirds of
the total number of proliferating cells in the Ercc1D/ brain.3.3. Enhanced sensitivity of Ercc1D/ microglia to LPS stimulation
Morphologically hypertrophic microglia can be functionally
primed or activated. It is possible to differentiate between these
states as primed cells do not (yet) express high amounts of in-
ﬂammatory cytokines but are hypersensitive to inﬂammatory
stimuli (Ramaglia et al., 2012; Sierra et al., 2007). To further sub-
stantiate possible immune priming, the proinﬂammatory
response of microglia in Ercc1D/ mice was studied after intra-
peritoneal LPS injection. Three hours after LPS injection, microglia
were isolated and transcript levels were determined using quan-
titative reverse transcription polymerase chain reaction. Basal
expression levels of cytokines IL-1b, TNFa, and IL6 were similar in
WT and Ercc1D/ mice. IL-1b, IL-6, and TNFa expression were
induced by LPS, notably, this increase in expression was much
more pronounced in Ercc1D/ microglia (Fig. 3AeC). Expression
levels of the typical anti-inﬂammatory cytokine IL-10 were com-
parable between WT and Ercc1D/ microglia both under basal
conditions and after LPS stimulation (Fig. 3D). TGF-b expression
was reduced in Ercc1D/ mice (w2-fold) and is induced to com-
parable expression levels as WT by LPS (Fig. 3E). A potential
interaction between genotype and LPS treatment was assessedFig. 3. Increased cytokine and Mac-2 expression of Ercc1D/ microglia after peripheral LPS
peritoneal injection with PBS or LPS (1 mg/kg, 3 hours) and relative mRNA expression levels w
(A), TNFa (B), and IL-6 (C) was signiﬁcantly increased in response to LPS with a much highe
Ercc1D/ mice had comparable basal anti-inﬂammatory IL-10 (D) expression levels and in r
microglia, which was restored to WT levels after LPS injection. The number of Mac2 expre
injection. The number of Mac-2 expressing cells was further increased in Ercc1D/ brains
Abbreviations: Ercc1D/, Ercc1 mutant mice; LPS, lipopolysaccharide; mRNA, messenger RNusing a general linear model-multivariate test. A signiﬁcant
interaction between genotype and LPS treatment was observed
the proinﬂammatory cytokines IL-1b, TNFa, IL6, and anti-
inﬂammatory cytokine TGF-b. (Supplementary Table 2).
Interestingly, expression of MHC-II, reported to be important
for microglia immune activation and antigen presentation
(Benveniste et al., 2001; Town et al., 2005) was not detected in
Ercc1D/ mice (Supplementary Fig. 2). LPS hypersensitivity of
Ercc1D/ microglia was further substantiated by the co-staining
with Iba1 and Mac-2, a marker for microglia activation. In WT
animals, Mac-2 was not detected under basal conditions and only a
small number of Mac-2 expressing Iba1þ cells were observed after
LPS stimulation. In Ercc1D/ mice, the number of Mac-2 expressing
microglia was higher than in WT mice and signiﬁcantly induced by
LPS, an observation further supporting a primed microglia pheno-
type in Ercc1D/ mice (Fig. 3F). In summary, Ercc1D/ microglia
display an exaggerated proinﬂammatory response, indicative of a
“primed” state and Mac-2 expression marks a subpopulation of
microglia that switched to an inﬂammatory state and is responsive
to inﬂammatory stimuli.3.4. Ercc1D/ microglia display increased phagocytosis and reactive
oxygen species (ROS) production
Removal of cellular debris by phagocytosis is an essential func-
tion of microglia, which might change upon aging. It is unknown if
primed and resting microglia have similar functional capacities.
Microglia phagocytic activity was determined using pHrodo-
coupled E. coli bioparticles. Fluorescence emission by pHrodo was
plotted over time for 40WT and Ercc1D/microglia from 3 differentchallenge. Microglia were sorted from WT and Ercc1D/ mice (16 weeks), after intra-
ere determined by quantitative RT-PCR. Expression of proinﬂammatory cytokines IL-1b
r expression in Ercc1D/ microglia compared to WT microglia. Microglia from WT and
esponse to LPS. Basal TGFb (E) expression in Ercc1D/ microglia was almost half of WT
ssing cells (F) was higher in Ercc1D/ brains compared with WT mice, even after LPS
upon LPS injection. * p < 0.05, ** p < 0.005, *** p < 0.001, and ns: not signiﬁcant.
A; WT, wild type.
Fig. 4. Enhanced phagocytosis and ROS production by Ercc1D/ microglia. (A) Acutely isolated microglia were incubated with pHrodo-coupled Escherichia coli and pHrodo ﬂuo-
rescence is plotted against time (in hours). Ercc1D/microglia have a higher rate of phagocytic uptake compared with WT microglia, which is further increased by LPS. (B) At the end
of the experiment (13 hours), total ﬂuorescence per cell (40 cells per category) was plotted with WT set at 100%, showing higher phagocytic intake by Ercc1D/ microglia; which was
further enhanced by LPS; * p < 0.05. Ercc1D/ microglia express increased levels of phagocytic receptors CD36 (C) TREM2b (D) and CD14 (E) as measured by ﬂow cytometry; gray-
ﬁlled histograms depict isotype controls. (F) Mac2-positive Ercc1D/ microglia engulﬁng a cell in the hippocampus. (G) Increased reactive oxygen species production by Ercc1D/
compared with WT microglia acutely isolated from LPS stimulated mice. *** p < 0.0001; ns: not signiﬁcant, 1-way ANOVA. Abbreviations: ANOVA, analysis of variance; Ercc1D/,
Ercc1 mutant mice; LPS, lipopolysaccharide; ROS, reactive oxygen species; WT, wild type.
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activity of microglia isolated from WT and Ercc1D/ mice injected
with LPS (1 mg/kg body weight) was determined. Ercc1D/ micro-
glia showed signiﬁcantly increased phagocytic activity compared
with WT microglia (Fig. 4B) and peripheral LPS injection further
increased phagocytosis of pHrodo coupled E. coli bioparticles,
which was more pronounced in Ercc1D/ microglia.
As Ercc1D/ microglia displayed enhanced phagocytic activity,
the expression of phagocytic receptors CD36, TREM2b, and CD14
was determined. Increased expression of these phagocytic
receptors was observed in Ercc1D/ microglia in vivo (Fig. 4CeE). In
addition, cell engulfment was observed by Mac2-positive microglia
in Ercc1D/ mice suggesting active phagocytic intake in vivo
(Fig. 4F). Production of reactive oxygen species (ROS) by microglia
was measured using ﬂow cytometric measurement of 20,70-
dichloroﬂuorescein diacetate (DCFDA) ﬂuorescence. Under basal
conditions, no signiﬁcant difference in ROS production betweenWT
and Ercc1D/microgliawas observed. However, upon peripheral LPS
injection, a signiﬁcant increase in ROS production was observed in
Ercc1D/ microglia (Fig. 4G). Summarizing, these results show
increased phagocytosis and ROS production in Ercc1D/ microglia,
and this increase is further enhanced by LPS, suggesting that
primed microglia are functionally hyper-responsive.3.5. Transcriptional proﬁle of primed microglia
To determine the gene expression proﬁle of primed microglia,
RNA from pure FACS-sortedWTand Ercc1D/microglia was isolated
and hybridized to Illumina expression arrays. Co-expression
network analysis was used to identify gene networks associated
with microglia priming. Weighted gene co-expression network
analysis (WGCNA) was applied to construct a gene co-expression
network of microglia in Ercc1D/ mice. After ﬁltering lowly con-
nective genes, a network of 2904 genes was generated. Two co-
expression networks were identiﬁed with signiﬁcant differential
expression betweenWT and Ercc1D/mice (Fig. 5A). Kruskall Wallis
nonparametric 1-way analysis of variance was used to calculate
between group differences (the bluemodule: p¼ 6.7 106, yellow
module: p ¼ 2.9  105). The genes in the blue module are upre-
gulated in Ercc1D/ microglia, and the genes in the yellow module
are downregulated in Ercc1D/ microglia (Fig. 5B). These up and
downregulated gene modules were combined in a module mem-
bership or kME-table and used as input for IPA. IPA showed that the
following immune-related signaling pathways were upregulated in
Ercc1D/microglia, particularly communication between innate and
adaptive immune cells, antigen presentation, complement system,
role of pattern recognition receptors, activation of microglia, and
Fig. 5. Network and pathway analysis of microarray data from Ercc1D/ microglia. (A) Dendrogram and associated gene modules. The dendrogram is produced by average linkage
hierarchical clustering of genes based on topological overlap. Modules were assigned colors as indicated in the horizontal bar below the dendrogram. (B) Bar graphs and heatmaps
showing the blue and yellow module EigenGene (ﬁrst principal component, a representative of the module) and the associated genes expression values. Tables show canonical
pathways (C) or biological functions (D) from ingenuity pathway analysis signiﬁcantly increased in Ercc1D/ microglia. Abbreviation: Ercc1D/, Ercc1 mutant mice. (Please refer to
Neurobiology of Aging online for color reproduction.)
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other IPA functions such as cell migration, inﬂammatory response,
adhesion of immune cells, activation of microglia, phagocytosis was
observed in Ercc1D/ microglia (Fig. 5D). Taken together, network
and pathway analyses indicated an enhanced immune state of
Ercc1D/ microglia with a clear phagocytic and chemotactic proﬁle.
3.6. Microglial priming is induced by genotoxic stress in
Ercc1D/-targeted forebrain neurons
Mac-2 has been shown to be expressed by activated microglia
(Rotshenker, 2009) and in the Ercc1D/ brains, Mac-2 was found to
be expressed in a “switched” microglia subpopulation. To deter-
mine the localization and distribution of these switched cells, brain
sections from 16-week-old WT and Ercc1D/ mice were co-stained
for Iba1 and Mac-2. In WT mice, Iba1-positive microglia displayed
a resting (highly ramiﬁed, small cell soma) phenotype and no Mac-
2 positive microglia were found (Fig. 6AeD, insets are enlarged in
panels E and F). In Ercc1D/ mice, Ibaþ microglia displayed an
altered morphology (also see Fig. 1, thickened processes, enlarged
soma), with extensive co-expression of Mac-2 (Fig. 6GeJ; insets are
enlarged in panels K and L). Mac2 immunoreactivity was restricted
to Iba1þ cells andmost pronounced inwhitematter tracts including
the corpus callosum and the anterior commissure. Also the brain
stem, particularly the mesencephalic reticular formation (MesRF),
contained extensive Mac-2 positive microglia. This observation, in
combination with the notion that particularly neurons suffer from
DNA-damage accumulation (Borgesius et al., 2011), led us to hy-
pothesize that genotoxic damage to neurons resulted in the
observed microglia priming and activation. To determine if the
observed morphologic changes and Mac2 expression by microglia
indeed were induced by genotoxic stress in neurons, the Ercc1f/
deletion was speciﬁcally targeted to CamK2-expressing forebrain
neurons (CamK2-Cre/Ercc1f/) and to GFAP-expressing astrocytes
(GFAP-Cre/Ercc1f/). Detailed characterization of generic Ercc1D/
mice revealed that microglia priming and activation was observedin all brain regions and that the intensity of priming-associated
hypertrophy was much more pronounced in the medulla
compared with the cortex (Fig. 1). The neocortex of Ercc1D/ mice
showed robust microglial hypertrophy (Fig. 7B, magniﬁed image in
G) in comparison to control micewith the same genetic background
(Ercc1þ/þ; Fig. 7A). Microglia hypertrophy was much more pro-
nounced in the brain stem (MesRF) of generic Ercc1D/mice (Fig. 7J)
and while Mac-2 expression was rarely detected in the cortex of
Ercc1D/ mice, the medulla showed abundant Mac-2 expression
(compare Fig. 7, panels G and J) possibly indicating more extensive
“switching” of microglia in the hindbrain. In Camk2-Cre/Ercc1f/
mice, microglia hypertrophy and Mac2 immunoreactivity were
restricted to the neocortex (Fig. 7D, magniﬁed image in I), whereas
no microglia hypertrophy or Mac-2 expression was observed in
hindbrain regions of Camk2-Cre/Ercc1f/mice (Fig. 7L) or in Camk2-
Cre/Ercc1f/þ control mice (Fig. 7K). This showed that priming
microglia (based on an hypertrophic morphology and Mac-2
expression) was restricted to the region of forebrain neurons tar-
geted by the Camk2-Cre transgene. In the GFAP-targeted Ercc1f/
mice, no microglial hypertrophy or Mac2 expression was observed
(Fig. 7F) indicating that DNA damage accumulation in astrocytes did
not induce microglia hypertrophy or priming. Microglia priming
was further substantiated by CD68 expression in the cortex of 16-
week-old control and Ercc1D/ mice and 26-week-old Camk2-Cre/
Ercc1f/ mice (Fig. 7MeO).
A time-course of microglia priming was determined in forebrain
sections of 8, 16, and 26-week-old Camk2-Cre/Ercc1f/ mice (Fig. 8).
An age-dependent change in microglia morphology and increase in
Iba1 intensity was observed in Camk2-Cre/Ercc1f/mice (Fig. 8AeD).
Both in lamina II/III and V, a primed microglia morphology was ﬁrst
observed at week 16 and more pronounced at 26 weeks (Fig. 8EeL).
Mac-2/Iba1 co-expression was ﬁrst observed after 26 weeks
(Fig. 8AeL). Interestingly, at 8 weeks, clusters of tubular microglia,
or rod cells, postulated to be involved in neuroprotection, appeared
in lamina V of the cortex (Fig. 8JeL) (Graeber, 2010; Lambertsen
et al., 2011; Wierzba-Bobrowicz et al., 2002; Ziebell et al., 2012).
Fig. 6. Localization of primed microglia in Ercc1D/ brains. Co-staining of 16-week-old WT (panels AeF) and Ercc1D/ (panels GeL) sections with Iba1 (green) and Mac-2 (red) to
identify localization and distribution of primed microglia. Mac2-positive microglia were largely found in Ercc1D/white matter tracts. Corpus callosum (cc) and anterior commissure
(ac) showed several Mac2-positive microglia (panel G and inset K). Also brain stem, in particular the mesencephalic reticular formation (MesRF) contained abundant Mac2-positive
microglia (panel I and inset L). The scale bar indicates 500 mm in panels AeD and GeJ and 50 mm in panels E, F, K, and L. Abbreviations: ac, anterior commissure; C, cortex; DG,
dentate gyrus; Ercc1D/, Ercc1 mutant mice; Hip, hippocampus; LV, lateral ventricle; NCx, neocortex; PAG, periaqueductal gray; Pir, piriform cortex; Str, striatum; WT, wild type.
(Please refer to Neurobiology of Aging online for color reproduction.)
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ablation of Ercc1 in forebrain neurons, local microglia acquire a
morphology associated with priming in a time-dependent fashion
and eventually somemicroglia expressMac-2, possibly indicative of
a more inﬂammatory state.
4. Discussion
Microglia priming as characterized by exaggerated proin-
ﬂammatory response has been shown in the aged brain (Henryet al., 2009; Sierra et al., 2007) and is associated with neurode-
generative diseases (Cunningham et al., 2009; Dantzer et al., 2008;
Norden and Godbout, 2013; Perry et al., 2007). Classically in
neuropathology, microglia have been categorized into a resting,
ramiﬁed form and a completely de-ramiﬁed, activated form.
However, a spectrum of “intermediate” morphologies exists which
have been described in literature as “reactive,” “intermediate,” and
“hypertrophic” and have been viewed as both activated as well as
primed microglia (Ayoub and Salm, 2003; Beynon and Walker,
2012; Gomide et al., 2005; Hwang et al., 2008; Karperien et al.,
Fig. 7. Microglial priming response to forebrain neuron-targeted DNA repair deﬁciency. Sections of forebrain neuron-targeted and astrocyte-targeted Ercc1f/- from 26-week-old mice
were co-stained for Iba1 (green) and Mac-2 (red). Microglia in transgenic control mice brains (A, C, E, H, and K) showed ramiﬁed and non-primed microglia whereas microglia in the
cortex of Camk2 targeted Ercc1 brains (Camk2-Cre/Ercc1f/) (D, I) showed a primed hypertrophic morphology. Brain stem region of Camk2-Cre/Ercc1f/ brains (L) (which do not suffer
Ercc1 ablation) did not display microglia hypertrophy. Cortex (B, G) and brain stem (J) of 16-week-old Ercc1D/ brains show hypertrophic microglia and increased Mac2 positivity. In
26-week-old astrocyte (GFAP) targeted Ercc1/ mice (F), the cortex shows ramiﬁed, non-primed microglia comparable to its transgenic control (E). An additional marker for
microglia priming, CD68 was shown to be expressed both in 16-week-old Ercc1D/ mice as (N) well as in 26-week-old Camk2-Cre/Ercc1f/ mice (O). Scale bars indicate 50 mm.
Abbreviation: Ercc1D/, Ercc1 mutant mice. (Please refer to Neurobiology of Aging online for color reproduction.)
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Fig. 8. Characterization of microglia priming in Camk2 targeted Ercc1 mice. The time-course of microglia priming was determined in 8-, 16-, and 26-week-old Camk2-Cre/Ercc1f/
mice, compared with 26-week-old Ercc1f/ mice. The sections were co-stained for Iba1 (green) and Mac-2 (red). Panels A, B, C, and D show an overview of 26-week-old Ercc1f/ mice
(A) and 8- (B), 16- (C), and 26-(D) week-old Camk2-Cre/Ercc1f/ mice, where an age-dependent increase in Iba1 intensity and changes in microglia morphology was observed. Mac-2
expression was most apparent in 26-week-old mice. Both in lamina II/III and V, a change toward a hypertrophic morphology occurred at week 16 (G, K) and was more pronounced at
26 weeks (H, L). Interestingly, at 8 and 16 weeks (J, K) long shaped clusters of so-called tubular microglia were observed in lamina V (white arrows). Scale bars indicate 50 mm. (M).
Abbreviation: Ercc1D/, Ercc1 mutant mice. (Please refer to Neurobiology of Aging online for color reproduction.)
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morphology, in correlation to altered function, have previously
been shown in models of tissue injury (Davis et al., 1994; Graeber
and Streit, 2010; Stence et al., 2001; Streit et al., 1999). More
recently, dynamic remodeling of microglia, particularly the extent
of ramiﬁcation, was reported to be important in monitoring,
regulating, and responding to synaptic activity in the brain
(Nimmerjahn et al., 2005; Wake et al., 2009). In a model of chronic
stress, microglia have been shown to respond by increasing the
extent of secondary branching in the prefrontal cortex, correlating
to local neuronal activity, and behavioral changes (Hinwood et al.,
2012). Although it is difﬁcult to directly link morphology to func-
tion, changes in microglia morphology are a clear indication of
perturbed brain homeostasis.
Ercc1D/ microglia showed a hypertrophic morphology (thick-
ened arbors and larger cell bodies) and extensive proliferation.
With digital morphometric analysis in the cortex, microglia process
length increased, whereas in the medulla microglia processes were
shortened. Microglial hypertrophy and enhanced responsiveness to
systemic inﬂammation has been shown previously in a prion dis-
ease model where microglia are primed (Gómez-Nicola et al., 2013;
Perry et al., 2007). Interestingly, enhanced production ofproinﬂammatory cytokines after an inﬂammatory stimulation, a
hallmark of microglia priming, has been reported in aged mouse
microglia (Godbout et al., 2005; Sierra et al., 2007). A similar LPS
hyper-responsiveness, proliferation and hypertrophy was observed
in Ercc1D/ microglia, indicating that microglia are primed in this
model of DNA repair deﬁciency.
The effect of priming on microglia functionality has not been
explored yet. Ercc1D/ microglia showed higher expression of
phagocytic receptors (Fig. 5) and show increased phagocytic ac-
tivity, whichwas further enhanced by LPS. Furthermore, production
of reactive oxygen species was enhanced in microglia upon LPS
stimulation. Summarizing, the data show that primed Ercc1D/
microglia display enhanced phagocytic activity and ROS production.
Also, these functions are hyper-responsive to LPS. Using expression
proﬁling and subsequent WCGNA analysis of Ercc1D/-derived
microglia, a priming-associated expression network was identiﬁed
that contained many immune signaling related genes. Interestingly,
several genes upregulated in Ercc1D/ microglia are also increased
in expression in physiologically aged microglia (Hickman et al.,
2013).
Notably, messenger RNA (mRNA) expression of MHC-II complex
encoding H2 genes was increased in Ercc1D/ microglia, an
D.D.A. Raj et al. / Neurobiology of Aging 35 (2014) 2147e21602158observation in agreement with data obtained in aging mice where
increased CD68 and MHC II mRNA levels were observed (Godbout
et al., 2005). Increased MHC II protein expression has been re-
ported in aged human and primate brain (Dickson et al., 1992;
Shefﬁeld and Berman, 1998). Surprisingly, in Ercc1D/ mice MHC-
II protein expression was not detected on microglia whereas
phagocytic markers like Mac2 and CD68 showed robust expression.
Moreover, LPS injection in Ercc1D/ mice resulted in a signiﬁcant
increase in the number of Iba1/Mac2 positive cells, muchmore than
in WT mice, indicating the presence of an increased number of
microglia poised to switch to an inﬂammatory state in Ercc1D/
mice. Additionally, Mac2þ microglia often showed phagocytic in-
clusions. Ercc1D/ microglia therefore likely present a phenotype
that is adapted to phagocytic clearance but not (yet) immune
activated in the absence of an inﬂammatory stimulus. When
stimulated, these microglia possibly switch to a proinﬂammatory
state. However, isolation and inﬂammatory analysis of Mac2þ and
Mac2 subpopulations of microglia would be required to further
substantiate this hypothesis.
Previously, it was shown that DNA damage accumulation in
Ercc1D/ mice primarily affected neurons and to a small extent as-
trocytes. Markers of genotoxic stress such as p53 and ATF3 were
rarely detected in microglia (De Waard et al., 2010). We hypothe-
sized that neuronal distress in this aging model could be the cause
of the observed microglia priming. Analysis of Camk2-targeted
Ercc1f/ (Camk2-Cre/Ercc1f/) mice, where DNA damage is specif-
ically targeted to forebrain neurons showed that Mac2 and CD68
expression was restricted to the forebrain (Fig. 7). Progressive
microglia priming was observed from 8 to 26 weeks in Camk2-Cre/
Ercc1f/ mice. Furthermore, the morphology of primed microglia in
Camk2-Cre/Ercc1f/ mice was highly similar to the morphology of
Ercc1D/ microglia (Fig. 8). Therefore, microglia priming (based on
hypertrophic morphology and Mac2 and CD68 expression) was
restricted to forebrain regions expressing the Camk2-Cre transgene.
Although astrocytes are susceptible to DNA damage, microglia
priming did not occur in astrocyte-targeted Ercc1/ mice (De
Waard et al., 2010). These observations strongly suggest that the
priming response in microglia was instigated by neuronal
dysfunction; it is unclear why neurons are relatively sensitive to
impaired Ercc1 activity, since it is unknown which types of lesions
accumulate in Ercc1 impaired cells.
In the cortex 8- to16-week-old Camk2-Cre/Ercc1f/ mice, micro-
glia rod cells were observed (Fig. 8). Rod cells are longitudinally
shapedmicroglia that typically alignwith apical dendrites (Graeber,
2010) and have been associated with neural protection in cerebral
ischemia (Lambertsen et al., 2011), Alzheimer’s disease (Wierzba-
Bobrowicz et al., 2002), and traumatic brain injury (Ziebell et al.,
2012). Rod cells were exclusively found in the lamina of the cortex
and preceded the occurrence of Mac2 expression in microglia sug-
gesting that rod cells are the ﬁrst indicators of cellular stress of py-
ramidal cells in lamina V. These data suggest that genotoxic stress in
Camk2-targeted neurons induced microglia priming.
While accumulation of DNA damage could potentially induce a
“senescence-like” state in neurons (Jurk et al., 2012), perturbed
transcriptional initiation might also cause neuronal dysfunction
(Barzilai et al., 2008; Brooks, 2008) and as a result trigger immune
activation. Indeed, the late phase long-term potentiation stage of
synaptic transmission that is dependent onmRNA transcription and
protein synthesis (Kelleher et al., 2004) has been shown to be
affected in Ercc1D/ mice (Borgesius et al., 2011). It is likely that
dysfunctional neurons affected by DNA damage communicate with
microglia using several routes. While enhanced LPS reactivity has
been used to characterize primed microglia in this study, the aging
brain offers alternative priming triggers including complement
proteins and adenosine triphosphate. In line with this reasoning, anincrease in complement system activity has been previously re-
ported in primed microglia (Eikelenboom and Veerhuis, 1996;
Ramaglia et al., 2012) and increased complement gene expression
was observed in Ercc1D/ microglia.
The link between DNA damage events, inﬂammation, and tissue
speciﬁc degeneration is only beginning to be understood. Inter-
estingly, a chronic cell-autonomous inﬂammatory response has
been shown to occur in Ercc1-deﬁcient adipocytes that led to
recruitment of leukocytes and ultimately resulted in adipose tissue
degeneration (Karakasilioti et al., 2013). A recent study showed that
loss of NF-kB signaling delayed DNA damage-induced aging and
senescence (Tilstra et al., 2012). These studies suggest that DNA
damage and transcriptional initiation defects-induced neuronal
dysfunction could instigate an inﬂammatory reaction, possibly
ampliﬁed by microglia in the brain, leading to the cognitive
dysfunction associated with NER defects and by analogy aging. The
existence and characteristics of an inﬂammatory phenotype in ag-
ing neurons remains to be studied.
In conclusion, our data strongly suggest that the microglial
immune priming observed in this DNA repair deﬁcient model of
accelerated aging most likely is the consequence of an affected
neuronal environment. The observed enhanced phagocytic activ-
ity might suggest that initially the priming response of microglia
might support the degenerating brain. However, in case of
persistent microglia stimulation by a degenerating brain envi-
ronment or by an additional inﬂammatory stimulus, these primed
microglia display an enhanced reactivity particularly in terms of
cytokine secretion and ROS production. This might have serious
implications for the extent of neurodegeneration induced by in-
sults such as infections and stroke in segmental progeroid syn-
dromes caused by defective NER such as xeroderma pigmentosum,
Cockayne syndrome, and trichothiodystrophy. Although direct
extrapolations from progeroid models to physiological aging
should be treated with restraint, understanding the signaling
mechanisms that lead to enhanced reactivity in microglia might
also help understand priming in the naturally aging brain and
reveal if microglia priming is a potential confounding factor in
neurodegenerative pathologies.Dislosure statement
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